# Labeling OTC Human Drug Products Updating Labeling in RLDs and ANDAs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/labeling-otc-human-drug-products-updating-labeling-in-rlds-and-andas/f3147bb2-3c37-41e5-8e86-75e7c535af06

> FDA guidance document: Labeling OTC Human Drug Products Updating Labeling in RLDs and ANDAs. Issue date: October 18, 2002. Get complete insights and analysis.

---

## Details

- Title: Labeling OTC Human Drug Products Updating Labeling in RLDs and ANDAs
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2002-10-18
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2001-D-0135">FDA-2001-D-0135</a>

## Related Documents

- [Prussian Blue Drug Products — Submitting a New Drug Application](https://www.globalkeysolutions.net/guidances/guidance-document/prussian-blue-drug-products-submitting-a-new-drug-application/50eeb151-80bd-4aa2-8526-e3d53b652af5)
- [Nonclinical Safety Evaluation of Pediatric Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-safety-evaluation-of-pediatric-drug-products/a5729b5c-7a6e-40c1-861d-e8acf3cd178a)
- [Labeling OTC Human Drug Products Using a Column Format](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-otc-human-drug-products-using-a-column-format/538c56e4-5604-47c8-9451-300e5f66cf8f)